Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2009
03/26/2009WO2009039091A1 Method of treatment
03/26/2009WO2009039069A1 Method and compositions for treatment or prevention of inflammatory conditions
03/26/2009WO2009038974A1 Compounds and compositions as modulators of gpr119 activity
03/26/2009WO2009038913A2 Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
03/26/2009WO2009038879A2 Stem cell differentiating agents and uses therefor
03/26/2009WO2009038842A2 Methods and compositions to inhibit edema factor and adenylyl cyclase
03/26/2009WO2009038812A1 Condensed piperidine derivatives useful as vanilloid receptor ligands
03/26/2009WO2009038796A1 Methods of treatment for hemolysis
03/26/2009WO2009038784A1 Triazole fused heteroaryl compounds as p38 kinase inhibitors
03/26/2009WO2009038775A1 Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
03/26/2009WO2009038764A1 Fluoro-containing derivatives of hydrogented pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use
03/26/2009WO2009038759A2 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders
03/26/2009WO2009038757A2 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
03/26/2009WO2009038732A1 Use of r(+)-n-propargyl-1-aminoindan to treat or prevent hearing loss
03/26/2009WO2009038708A1 Therapeutic regimens for the treatment of immunoinflammatory disorders
03/26/2009WO2009038707A2 Cancer-testis gene silencing agents and uses thereof
03/26/2009WO2009038701A2 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same
03/26/2009WO2009038695A1 Method of treating gaucher disease
03/26/2009WO2009038685A1 Ligands for copper-catalyzed azide-alkyne cycloaddition reactions
03/26/2009WO2009038684A1 Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml)
03/26/2009WO2009038683A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
03/26/2009WO2009038681A1 Thiazolidinedione analogues for the treatment of hypertension
03/26/2009WO2009038673A2 Thieno-and furo-pyrimidine modulators of the histamine h4 receptor
03/26/2009WO2009038671A2 Oxylipin compounds for treating autoimmune diseases
03/26/2009WO2009038666A2 Compositions and methods for the identification of inhibitors of retroviral infection
03/26/2009WO2009038656A1 Mitochondria-targeting antioxidant therapeutics
03/26/2009WO2009038533A1 Method and means for the treatment of cachexia
03/26/2009WO2009038514A1 A system and method to improve sensory function
03/26/2009WO2009038289A2 Pharmaceutical compositions for preventing or treating fibrosis
03/26/2009WO2009038288A1 Pharmaceutical compositions for preventing or treating cataract
03/26/2009WO2009038204A1 Novel long-chain fatty acid derivative compound and g-protein-coupled receptor agonist containing the compound as active ingredient
03/26/2009WO2009038157A1 2,3-dihydroiminoisoindole derivative
03/26/2009WO2009038112A1 Solid preparation comprising npyy5 receptor antagonist
03/26/2009WO2009038110A1 Agent having neurotrophic factor-like activity
03/26/2009WO2009038107A1 Combined pharmaceutical preparation for treatment of type-2 diabetes
03/26/2009WO2009038095A1 Composition comprising sesamin component and vitamin b1 component
03/26/2009WO2009038092A1 Anti-fatigue agent comprising arachidonic acid as active ingredient
03/26/2009WO2009038090A1 Composition comprising sesamin component and arachidonic acid component
03/26/2009WO2009038089A1 Anti-fatigue agent comprising sesamin and vitamin-e
03/26/2009WO2009038064A1 Heterocyclic derivative having inhibitory activity on type-i 11β-hydroxysteroid dehydrogenase
03/26/2009WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
03/26/2009WO2009038021A1 4-sulfonylpiperidine derivatives
03/26/2009WO2009038012A1 Heterocyclic compound
03/26/2009WO2009038008A1 Process for producing fine particles and the fine particles
03/26/2009WO2009037813A1 Transdermally absorbable preparation
03/26/2009WO2009037719A1 Novel compounds as dipeptidyl peptidase iv (dpp iv) inhibitors
03/26/2009WO2009037707A2 N-phenyl anthranilic acid derivatives and uses thereof
03/26/2009WO2009037705A2 Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation
03/26/2009WO2009037704A1 Compositions and means for treating uterine leiomyomata, leiomyoma, myoma, uterine fibroids, endrometriosis, adenomyosis and related disorders by mifepristone
03/26/2009WO2009037592A2 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/26/2009WO2009037584A2 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease
03/26/2009WO2009037581A2 Use of vitamin b12 for treatment of mucosal lesions
03/26/2009WO2009037556A1 New agents for the treatment of the low urinary tract dysfunctions
03/26/2009WO2009037538A2 Process for the preparation of lamivudine form i
03/26/2009WO2009037512A1 Therapeutic methods 013
03/26/2009WO2009037485A1 Antibacterial agents
03/26/2009WO2009037468A1 Thienopyrimidine compounds and compositions
03/26/2009WO2009037467A1 Pyrrolopyrimidine compounds
03/26/2009WO2009037463A1 Thienopyrimidine compounds
03/26/2009WO2009037449A1 Solid pharmaceutical compositions comprising one or more herpes virus inhibitors and one or more reverse transcriptase inhibitors
03/26/2009WO2009037413A1 Dimers of 5- [ (4-cyanophenyl) sulfinyl] -6-methyl-2-oxo-1- [3- (trifluoromethyl)phenyl] -1,2-dihydropyridine-3-carboxamide as inhibitors of human neutrophil elastase for treating respiratory diseases
03/26/2009WO2009037398A2 Foodstuff composition to improve digestibility of foodstuff lipids
03/26/2009WO2009037394A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
03/26/2009WO2009037357A1 Benzimidazole nf- kappab inhibitors
03/26/2009WO2009037343A1 Inhibitors of the interaction between mdm2 and p53
03/26/2009WO2009037319A2 Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
03/26/2009WO2009037308A1 Inhibitors of the interaction between mdm2 and p53
03/26/2009WO2009037302A1 5-substituted-1, 4-benz0diazepines as phosphodiesterase inhibitors
03/26/2009WO2009037296A1 Compounds which have activity at m1 receptor and their uses in medicine
03/26/2009WO2009037294A1 Compounds which have activity at m1 receptor and their uses in medicine
03/26/2009WO2009037293A1 Compounds which have activity at m1 receptor and their uses in medicine
03/26/2009WO2009037262A2 Method of preventing early lawsonia intracellularis infections
03/26/2009WO2009037247A1 Pyrazine derivatives and their use as potassium channel modulators
03/26/2009WO2009037222A1 Diacylglycerol acyltransferase inhibitors
03/26/2009WO2009037220A1 Tricyclic heterocyclic derivatives
03/26/2009WO2009037183A2 Cosmetic and/or pharmaceutical preparation containing nucleic acid for the induction of antimicrobial peptides in epithelia
03/26/2009WO2009037172A1 Prodrugs to thyroid hormone analogs
03/26/2009WO2009037168A1 Heterocyclic antiviral compounds
03/26/2009WO2009037111A2 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions
03/26/2009WO2009037001A2 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
03/26/2009WO2009036996A2 Small molecule bradykinin b1 receptor antagonists
03/26/2009WO2009036971A1 Means and methods for shrna mediated conditional knockdown of genes
03/26/2009WO2009036955A1 Naphtyl-substituted sulfonamides
03/26/2009WO2009036938A1 Substituted nicotinamide compounds and the use thereof in pharmaceutical products
03/26/2009WO2009036933A2 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles
03/26/2009WO2009036852A1 Medicament for treating or preventing proteinuria
03/26/2009WO2009036766A1 Cyanoisoquinoline
03/26/2009WO2009036754A1 Inhibitors of the myelin-associated glycoprotein (mag)
03/26/2009WO2009036753A2 Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy
03/26/2009WO2009036714A1 Composition for the treatment of wounds, containing at least silver and urea
03/26/2009WO2009036712A2 Dosage form containing tramadol with controlled 24-hour release and a process for manufacturing the same
03/26/2009WO2009036656A1 Coumarin derivatives, preparation processes and uses thereof
03/26/2009WO2009036590A1 Compounds isolated from antrodia cinnamomea and use thereof
03/26/2009WO2009036574A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening
03/26/2009WO2009020631A3 Compounds for treating proliferative disorders
03/26/2009WO2009018373A3 Transdermal administration of (2s) - (4e) -n-methyl-5- (3- ( 5-is0pr0p0xypyridin) yl) -4-penten-2-amine
03/26/2009WO2009017948A3 Systems, methods and compositions for reduction of injury from radiation exposure
03/26/2009WO2009017825A3 Novel lipoxygenase inhibitors as neuroprotective agents
03/26/2009WO2009017812A3 Pharmaceutical composition of candesartan
03/26/2009WO2009017624A3 Compositions with enhanced bioavailability and fast acting inhibitor of gastric acid secretion
1 ... 2805 2806 2807 2808 2809 2810 2811 2812 2813 2814 2815 2816 2817 2818 2819 2820 2821 2822 2823 2824 2825 ... 7860